As seen on:
As seen on:














Latest Articles
Growth or income — we break down which approach gives Singapore investors the edge over time.
Three under-the-radar Singapore stocks significantly beat the 2.2% STI return in November 2025, demonstrating market-beating returns.
Three major Singapore blue-chip stocks stumbled in November, forcing investors to question if they offer a discount or signal a deeper red flag.
Centurion, AIMS APAC and FLCT emerged as November 2025’s best-performing REITs, outpacing the market with resilient portfolios and steady fundamentals.
November saw three Singapore blue-chip leaders beat the STI with standout performance powered by resilient fundamentals and strategic growth execution.
Beyond the Numbers: What a Site Visit Reveals About a Business That Investors Might Miss
Beyond the numbers lies the story. Our StarHub site visit shows how first-hand insights help investors understand the drivers behind a company’s performance.
Popular
We look at the recent news swirling around the telco space to identify which company benefits or loses out.
5 Singapore Companies Made it to Forbes Asia “Best Under a Billion” List: Should You Add Them to Your Buy Watchlist?
These five companies displayed attractive attributes that enabled them to qualify for this prestigious list.
These three dividend-paying stocks can not only give you peace of mind, but also increase your passive income flow.
Looking for stocks that you can keep for years or even decades? These four blue-chip companies may make the cut.
Stocks
Some REITs may stand to benefit from the Ministry of Trade and Industry’s newly released industrial land through its Industrial Government Land Sales (IGLS) programme.
Many investors leave their CPF untouched. This article explores why long-term investors consider using CPF to invest in stocks and how compounding can change retirement outcomes.
These three Singapore blue-chip stocks stand out for raising dividends, signalling earnings strength and management confidence.
When stocks hit multi-year highs, emotions often run ahead of fundamentals. How should investors think about valuation, momentum, and business quality at elevated prices?

















